Coforge (COFORGE) M&A Announcement summary
Event summary combining transcript, slides, and related documents.
M&A Announcement summary
29 Dec, 2025Strategic rationale and growth outlook
Acquisition creates a $2.5 billion tech services powerhouse with a $2 billion AI-led core, targeting accelerated growth and value creation for digital-native and Fortune 1000 clients.
Expands high-tech and healthcare verticals to $170 million each, with immediate scaling and new AI-led healthcare solutions.
Enhances global delivery with over 44,000 employees, strengthens nearshore LATAM delivery with 3,100+ engineers, and boosts North America revenue by 50% to $1.4 billion.
The combined firm will have 45 clients with $10 million+ relationships and a proven track record of cross-selling and upselling.
Unique distributed delivery model accelerates engineering velocity and client proximity.
Financial terms and conditions
The $2.35 billion enterprise value deal is structured as an all-stock transaction, with sellers receiving 93.8 million shares at INR 1,815.91 per share, reflecting an 8.5% premium to the signing date price.
Encora shareholders will hold approximately 20%-21% of the combined company on a fully diluted basis, assuming the Cigniti merger proceeds.
Funding includes $1.89 billion in equity shares and a potential $550 million bridge or term loan (or QIP) to retire Encora’s existing debt; QIP is one of several options and may not be triggered.
Encora’s FY26 estimated revenue is $600 million with a 19% adjusted EBITDA margin; the combined business is expected to operate at a 14% EBIT margin post-amortization and be EPS accretive.
Cost synergies of $20 million are assumed, driving a ~90 bps increase in combined EBITDA margin, with tax benefits from amortization in the US estimated at $4 million for FY27.
Synergies, integration, and leadership
Significant revenue synergies are anticipated from cross-selling broader service lines, especially leveraging Encora’s AI-led engineering.
Cost synergies are expected from G&A, S&M, and operational efficiencies, with only modest margin improvement assumed due to Encora’s strong profile.
Leadership retention will follow a proven playbook, with retention structures including stocks and bonuses; specifics to be finalized post-regulatory approvals.
Two Advent representatives will join the Board, bringing expertise and potential access to Advent’s portfolio companies.
No performance-linked consideration or special lock-ins beyond statutory requirements for incoming shareholders; client concentration and revenue per employee metrics are healthy and diversified.
Latest events from Coforge
- Strong revenue and margin growth, robust order intake, and interim dividend declared.COFORGE
Q1 24/253 Feb 2026 - Q3 FY26 saw strong revenue growth, record order book, and a $2.35B Encora acquisition approved.COFORGE
Q3 25/2623 Jan 2026 - Q2FY25 revenue up 34.5% YoY, EBITDA margin at 16.5%, and strong order intake.COFORGE
Q2 24/2519 Jan 2026 - Q3 FY25 saw 42.8% YOY revenue growth, record order book, and Rs. 19 interim dividend.COFORGE
Q3 24/259 Jan 2026 - FY25 revenue up 31.5% YoY, record orders, Cigniti acquired, Rs. 19/share dividend, share split.COFORGE
Q4 24/2523 Dec 2025 - Q2 FY26 saw 31.7% YoY revenue growth, 14% EBIT margin, and record order intake, with low attrition.COFORGE
Q2 25/2624 Oct 2025 - Q1 FY26 saw record revenue growth, margin gains, major deals, and a Rs. 4 interim dividend.COFORGE
Q1 25/2624 Jul 2025